Kegg medicus dgroup
| DG01585 | |
| DG番号 | DG01585 |
| 分類 | DGroup |
| 名称 | Estrogen receptor antagonist TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG01620 Tamoxifene-type antineoplastic DG00734 Tamoxifen D08559 Tamoxifen (INN) D00966 Tamoxifen citrate (JP18/USP) DG00735 Toremifene D08620 Toremifene (INN) D00967 Toremifene citrate (JAN/USAN) DG01265 Droloxifene D03911 Droloxifene (USAN/INN) D03912 Droloxifene citrate (USAN) D01853 Miproxifene phosphate (JAN) D02758 Acolbifene hydrochloride (USAN) D02993 Arzoxifene hydrochloride (USAN) D04496 Idoxifene (USAN/INN) D05106 Nafoxidine hydrochloride (USAN) D05192 Nitromifene citrate (USAN) D06084 Tesmilifene hydrochloride (USAN) D06245 Trioxifene mesylate (USAN) D06551 Afimoxifene (USAN/INN) D09380 Sivifene (USAN/INN) D01161 Fulvestrant (JAN/USP/INN) DG01992 Enclomiphene D08910 Enclomiphene (USAN) D10876 Enclomiphene citrate (USAN) D01265 Epitiostanol (JAN/INN) D01602 Mepitiostane (JP18/INN) D12628 Vepdegestrant (USAN/INN) |
| 上位グループ | Antineoplastic |
| 注釈1 | - |
| 注釈2 | - |